HAVCR2 and myelodysplastic syndrome: Besides immune cells, hematopoietic stem cells in myelodysplastic syndromes (MDS) [157] and leukemic stem cells (LSC) in acute myeloid leukemia (AML) can express TIM-3 [20, 158, 159].